Avita Medical Ownership
| RCEL Stock | USD 5.98 0.17 2.93% |
Shares in Circulation | First Issued 2012-03-31 | Previous Quarter 26.1 M | Current Value 26.4 M | Avarage Shares Outstanding 13.9 M | Quarterly Volatility 9.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. Avita Stock Ownership Analysis
About 27.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.19. Avita Medical had not issued any dividends in recent years. The entity had 1:5 split on the 30th of June 2020. AVITA Medical, Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. AVITA Medical, Inc. was incorporated in 2000 and is based in Valencia, California. Avita Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 116 people. To find out more about Avita Medical contact James Corbett at 661 367 9170 or learn more at https://avitamedical.com.Besides selling stocks to institutional investors, Avita Medical also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Avita Medical's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Avita Medical's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Avita Medical Quarterly Liabilities And Stockholders Equity |
|
Avita Medical Insider Trades History
Less than 1% of Avita Medical are currently held by insiders. Unlike Avita Medical's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Avita Medical's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Avita Medical's insider trades
Avita Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Avita Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avita Medical backward and forwards among themselves. Avita Medical's institutional investor refers to the entity that pools money to purchase Avita Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Wellington Management Company Llp | 2025-03-31 | 82.2 K | Nuveen Asset Management, Llc | 2024-12-31 | 71.7 K | Nuveen, Llc | 2025-03-31 | 71.7 K | D. E. Shaw & Co Lp | 2025-03-31 | 71.7 K | Charles Schwab Investment Management Inc | 2025-03-31 | 64.2 K | Jane Street Group Llc | 2025-03-31 | 63.7 K | Bank Of New York Mellon Corp | 2025-03-31 | 55.1 K | Delta Investment Management, Llc | 2025-03-31 | 52.5 K | Evernest Financial Advisors Llc | 2025-03-31 | 50.5 K | Blackrock Inc | 2025-03-31 | 1.8 M | Vanguard Group Inc | 2025-03-31 | 1.4 M |
Avita Medical Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avita Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avita Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Avita Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Avita Medical Outstanding Bonds
Avita Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Avita Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Avita bonds can be classified according to their maturity, which is the date when Avita Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| AVNET INC 4625 Corp BondUS053807AS28 | View | |
| AVT 55 01 JUN 32 Corp BondUS053807AV56 | View | |
| AVT 3 15 MAY 31 Corp BondUS053807AU73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Avita Medical Corporate Filings
8K | 5th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 2nd of June 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 22nd of April 2025 Other Reports | ViewVerify | |
| 11th of April 2025 Other Reports | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Avita Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For more information on how to buy Avita Stock please use our How to buy in Avita Stock guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avita Medical. If investors know Avita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avita Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share | Quarterly Revenue Growth 0.667 | Return On Assets | Return On Equity |
The market value of Avita Medical is measured differently than its book value, which is the value of Avita that is recorded on the company's balance sheet. Investors also form their own opinion of Avita Medical's value that differs from its market value or its book value, called intrinsic value, which is Avita Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avita Medical's market value can be influenced by many factors that don't directly affect Avita Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avita Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avita Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avita Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.